Intensity TherapeuticsINTS
13F holders, Q1 2025 (March 31)21holders +1
2new positions
1sold out
1famous investor
$1.97avg. 13F price*
At the end of Q1 2025, 21 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Sapient Capital LLC ($1.9M), Armistice Capital, LLC ($1.7M) and Vanguard Group Inc. ($454K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $81K |
| Exits | 1 | $34K |
All 13F filers, Q4 2024 → Q1 2025: 142,340 shares bought and 274,042 shares sold, net −131,702 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Sapient Capital LLC | 0.04% | Add +3.6% | 976,797 | $1.9M |
| Armistice Capital, LLC | 0.05% | Reduce -22.6% | 872,547 | $1.7M |
| Vanguard Group Inc. | 0.00% | Add +10.4% | 230,659 | $454K |
| Brown Advisory Inc. | 0.00% | No change | 130,072 | $256K |
| Geode Capital Management, LLC | 0.00% | Add +20.4% | 77,482 | $153K |
| Sigma Planning Corp | 0.00% | No change | 54,837 | $108K |
| Mesirow Financial Investment Management, Inc. | 0.00% | Add +100.0% | 40,000 | $79K |
| Blair William & Co. | 0.00% | No change | 37,805 | $74K |
| One Charles Private Wealth Services, LLC | 0.02% | No change | 31,800 | $63K |
| Rothschild Wealth LLC | 0.02% | New | 27,304 | $54K |
| Citadel Advisors | 0.00% | Add +72.4% | 25,801 | $51K |
| BlackRock, Inc. | 0.00% | Reduce -1.9% | 21,835 | $43K |
| QTR Family Wealth, LLC | 0.03% | — | 17,420 | $34K |
| State Street Corp. | 0.00% | No change | 14,500 | $29K |
| Northern Trust Corp. | 0.00% | New | 14,024 | $28K |
| Stonebridge Financial Group, LLC | 0.00% | Add +14.8% | 9,525 | $19K |
| UBS Group AG | 0.00% | Add +2.5% | 3,097 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -10.3% | 2,376 | $5K |
| Morgan Stanley | 0.00% | No change | 500 | $985 |
| Bank of America Corp. | 0.00% | Add +26.0% | 63 | $124 |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.8% | 15 | $30 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.